Open AccessIncrease in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT–PCR
Author(s) -
Dobryan M. Tracz,
David A. Boyd,
Louis Bryden,
Romeo Hizon,
Sandra Giercke,
Paul Van Caeseele,
Michael R. Mulvey
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki074
Subject(s) - cefoxitin , escherichia coli , attenuator (electronics) , microbiology and biotechnology , biology , ceftizoxime , enterobacteriaceae , antibiotics , virology , cephalosporin , gene , genetics , bacteria , staphylococcus aureus , physics , attenuation , optics
To characterize the mechanism of cefoxitin resistance in clinical isolate Escherichia coli N99-0001.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom